Protagonist Therapeutics, Inc PTGX
$155.10
+2.43%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | OWNERSHIP DOCUMENT | 2026-08-12 | View → |
| 10-Q | 10-Q | 2026-08-05 | View → |
| 8-K | FORM 8-K | 2026-08-05 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-25 | View → |
| 8-K | FORM 8-K | 2026-06-18 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-11 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-01 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-05-12 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-05-11 | View → |
| 10-Q | 10-Q | 2026-05-05 | View → |
| 8-K | FORM 8-K | 2026-05-05 | View → |
| DEF 14A | FORM- DEF 14A | 2026-04-28 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-04-24 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-04-21 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-27 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-27 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-27 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-03-25 | View → |
| 10-K | 10-K | 2026-02-25 | View → |
| 8-K | FORM 8-K | 2026-02-25 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-18 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-06 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-01-27 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-01-27 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-01-27 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-01-21 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-01-21 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-01-21 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-01-13 | View → |
| 8-K | FORM 8-K | 2026-01-12 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-01-06 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-01-06 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-01-06 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-01-06 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-01-06 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-01-06 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-01-06 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-01-06 | View → |
| 4 | OWNERSHIP DOCUMENT | 2025-11-24 | View → |
| 4 | OWNERSHIP DOCUMENT | 2025-11-19 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $155.10
- Market Cap
- $9.84 billion
- 52-Week Range
- $50.48 – $155.53
- Average Volume
- 627K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.